NT5C1B-RDH14

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, NT5C1B-RDH14 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated NT5C1B-RDH14 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NT5C1B-RDH14 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NT5C1B-RDH14 expression acts as an unfavorable survival marker, although some lineages such as SCLC show a favorable association.

KIRC, UCS, and THYM are the cancer types where NT5C1B-RDH14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCOSTertileAll0.6950.882.004108view →
UCSOSTertileIII,IV0.1270.606.00190view →
THYMOSTertileAll0.5850.879.00263view →
COADOSTertileAll0.0560.871<.00154view →
STADDFSTertileIV0.0930.479.00736view →
BLCAOSTertileIV0.0820.575.00218view →
SKCMOSTertileAll0.4970.784.00815view →
OVOSTertileAll0.7670.844.02212view →
GBMDFSTertileAll0.0710.288.0099view →
SCLCOSMedianIV0.7720.201.0249view →
LUADDFSTertileIII,IV0.2060.670.0159view →
LGGOSTertileAll0.5710.908.0129view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

NT5C1B-RDH14–KIRC (OS)

Kaplan–Meier survival curve for NT5C1B-RDH14 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration